Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
AIDS (London, England)|September 12, 2025
No evidence of an effect of the M184I/V on the doravirine/lamivudine/tenofovir switch efficacy in people with HIVCathia Soulié, Aliou Baldé, Djeneba Fofana, et al.
The Journal of Antimicrobial Chemotherapy|June 17, 2024
DORAVIR: a French national survey of people with HIV-1 treated with an antiretroviral regimen including doravirineCathia Soulie, Aliou Balde, Djeneba Fofana, et al.
Antimicrobial Agents and Chemotherapy|November 11, 2009
Factors associated with virological response to etravirine in nonnucleoside reverse transcriptase inhibitor-experienced HIV-1-infected patientsAnne-Genevieve Marcelin, Philippe Flandre, Diane Descamps, et al.
The Journal of Antimicrobial Chemotherapy|January 18, 2018
Phenotypic analysis of HIV-1 E157Q integrase polymorphism and impact on virological outcome in patients initiating an integrase inhibitor-based regimenCharlotte Charpentier, Isabelle Malet, Elisabeth Andre-Garnier, et al.
International Journal of Antimicrobial Agents|April 9, 2013
A cohort study of treatment-experienced HIV-1-infected patients treated with raltegravir: factors associated with virological response and mutations selected at failureAnne-Geneviève Marcelin, Constance Delaugerre, Céline Beaudoux, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|October 3, 2019
New HIV-1 circulating recombinant form 94: from phylogenetic detection of a large transmission cluster to prevention in the age of geosocial-networking apps in France, 2013 to 2017Marc Wirden, Fabienne De Oliveira, Magali Bouvier-Alias, et al.
The Journal of Antimicrobial Chemotherapy|October 27, 2014
Antiretroviral-naive and -treated HIV-1 patients can harbour more resistant viruses in CSF than in plasmaCathia Soulie, Diane Descamps, Maxime Grudé, et al.
The Journal of Antimicrobial Chemotherapy|February 22, 2019
Resistance to integrase inhibitors: a national study in HIV-1-infected treatment-naive and -experienced patientsAnne-Genevieve Marcelin, Maxime Grude, Charlotte Charpentier, et al.
The Journal of Antimicrobial Chemotherapy|May 5, 2017
Antiretroviral-treated HIV-1 patients can harbour resistant viruses in CSF despite an undetectable viral load in plasmaCathia Soulie, Maxime Grudé, Diane Descamps, et al.
The Journal of Antimicrobial Chemotherapy|October 24, 2019
Surveillance of HIV-1 primary infections in France from 2014 to 2016: toward stable resistance, but higher diversity, clustering and virulence?Benoit Visseaux, Lambert Assoumou, Nadia Mahjoub, et al.
Pageof 3